The declining risk of post-transfusion hepatitis C virus infection.
about
Hepatitis C: a review for primary care physiciansHepatitis C screening and blood safety.Role of hepatitis C virus in chronic liver disease occurring after orthotopic liver transplantationManaging Occupational Risks for Hepatitis C Transmission in the Health Care SettingImmunodiagnosis of viral hepatitides A to E and non-A to -EDetection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube seraDetermination of hepatitis C virus genotypes in the United States by cleavase fragment length polymorphism analysisPrevalence of antibodies to hepatitis C virus after blood transfusion in heart surgeryHepatology.Use of factor IX complex in warfarin-related intracranial hemorrhageHCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, BrazilVaccination of chimpanzees against infection by the hepatitis C virusDiagnosis, management, and treatment of hepatitis C: an updateKnowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the Childhood Cancer Survivor Study.Epidemiology of hepatitis C virus infection among injecting drug users in Australia.Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospitalRisk factors for hepatitis C virus infection among injecting drug users in SydneyA novel duplex real-time reverse transcriptase-polymerase chain reaction assay for the detection of hepatitis C viral RNA with armored RNA as internal control.Optimal blood donation screening annotation.Epidemiology of hepatitis C virus (HCV) infection.Current viral risks of blood and blood products.Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China.Valsartan: a novel angiotensin type 1 receptor antagonist.Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection.Haemoglobin-based erythrocyte transfusion substitutes.Interferon for acute hepatitis C.Hepatitis C: an epidemiological review.Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group.Prevalence of Hepatitis C among Multi-transfused Thalassaemic Patients in Oman: Single centre experience.Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis.Regional transfusion centre preoperative autologous blood donation programme: the first two years.The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling.Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.The Impact of Enhanced Screening and Treatment on Hepatitis C in the United StatesScreening asymptomatic people at high risk for hepatitis C. The case againstAntiviral treatment of hepatitis C.Seroprevalence of Hepatitis C, Hepatitis B, Cytomegalovirus, and Human Immunodeficiency Viruses in Multitransfused Thalassemic Children in Upper Egypt.Hepatitis C: progress and problems.[Are HVC patients on hemodialysis really difficult to treat patients?].Human Immunoglobulins for intravenous use and hepatitis C viral transmission.
P2860
Q22306040-50A6027B-B6E8-49D5-BC13-7E12AEA2733CQ27472762-3F009447-0418-4870-A7AF-29407534EFAEQ27473385-9307783E-48A2-45D7-B571-E3425A3DC3CBQ27477626-88B9477D-3338-4A2D-AE57-FF238E50707FQ27477783-C9CC5267-3904-4342-AB21-43D2025C8AC8Q27485714-4BA09531-2232-4346-A2F7-D25360D85A90Q27485824-1267725D-E980-4A0B-9C5D-337FCD998DF0Q27486160-0015F6CB-1434-4731-9B9B-0EF7953C0C99Q27486937-D23DDBFC-FBAB-48A0-B394-FAB313FF44D3Q28375864-E707043B-03DB-4A12-B52A-D9C8BFA431CEQ28538943-DEE5DAF2-8403-4BD6-9DBD-8CB1C863B82DQ29615899-C38DCBFE-073A-4E36-8297-30806105886EQ29619682-D7255E13-FC27-45C3-A5B6-8DE6094D0310Q33643564-A0CF7084-BDAE-4D6F-8C5A-127B21D86AD3Q33704770-42073009-3942-42CD-921D-1AEB10EEE497Q33762749-0BE249D1-9D81-44B9-86FA-370B3C3C3FE4Q33934996-66C64734-18E4-491E-B07E-1D1A0BB48C11Q33991980-306A4D28-C152-4203-887C-5958C9CDC068Q33992800-D0AC7167-C57A-48DB-B888-A36BC1379F3DQ33995067-F449414E-079D-4E34-9A2F-F8F5474C4266Q34087426-3B405B6F-EB7E-4E00-AB57-A3B7ED1B21D6Q34100073-2809E4C8-5413-43AA-BB4C-4A5A9C5EF0D3Q34182288-B87E162C-127B-4765-97BE-243AD05ADAA6Q34294938-4B86D558-B680-4773-9911-43483055DA0AQ34452641-46D19576-5F6C-4F8D-B1CE-5AD61707874DQ34546599-9DEE81E0-7CAA-44F6-ACB6-1BAF48A0C822Q34551348-B5A6BEA2-4AC7-4706-8089-5615ADC21273Q34712297-FFC4EF30-26E9-4969-AC03-057FB8B59722Q35054058-03B708AA-AAAF-47BA-BCE6-79E32D0A2458Q35596391-7E8AEC61-F50A-4D87-A576-62CCEB95D831Q35824949-E9C000DE-8B98-4D72-9FC8-0BA05E6EE59FQ35942065-8668C63F-E305-46F7-BEF0-F9C0134467E0Q36115014-3A2EBD22-B2D5-45F8-8FFF-8B768E709470Q36446133-98D1FF76-D72D-4CC3-A815-260F859E7050Q36598463-12AD5D42-18B0-4FE3-9D88-1051D34B1821Q36613917-CFB687F4-2F3A-43D6-A18E-4B0A7CE0595FQ36637457-AB019916-B5E0-4F88-96E0-173E38EF0690Q36642065-9796E127-D64B-471E-BBBC-3343ACF5EEB9Q36680222-D9767992-CAAD-4312-BB0F-EAEF22509B98Q36932236-4C44E062-0E77-4638-B66B-AC39D39BB2A4
P2860
The declining risk of post-transfusion hepatitis C virus infection.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The declining risk of post-transfusion hepatitis C virus infection.
@en
The declining risk of post-transfusion hepatitis C virus infection.
@nl
type
label
The declining risk of post-transfusion hepatitis C virus infection.
@en
The declining risk of post-transfusion hepatitis C virus infection.
@nl
prefLabel
The declining risk of post-transfusion hepatitis C virus infection.
@en
The declining risk of post-transfusion hepatitis C virus infection.
@nl
P2093
P1476
The declining risk of post-transfusion hepatitis C virus infection.
@en
P2093
Brown DE Jr
Donahue JG
McAllister HA Jr
P304
P356
10.1056/NEJM199208063270601
P407
P577
1992-08-01T00:00:00Z